HOOK (HOOKIPA Pharma) Insider Ownership: 4.60 % (As of Aug. 15, 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

HOOK HOOKIPA Pharma Inc HOOK
50 GF Score
Price $1.15
View Full Analysis

What is HOOKIPA Pharma Insider Ownership?

HOOKIPA Pharma HOOK 50 Insider Ownership is 4.60 % as of Aug. 15, 2026. GuruFocus rates HOOK with a GF Score™ of 50/100.

Insider ownership is the percentage of shares that are owned by company insiders relative to the total shares outstanding. As of today, HOOKIPA Pharma's insider ownership is 4.60%.

Institutional Ownership is the percentage of shares that are owned by institutions out of the total shares outstanding. As of today, HOOKIPA Pharma's Institutional Ownership is 7.24%.

Float Percentage Of Total Shares Outstanding is the percentage of float shares relative to the total shares outstanding. As of today, HOOKIPA Pharma's Float Percentage Of Total Shares Outstanding is 65.43%.

HOOKIPA Pharma Insider Ownership Historical Data

* Premium members only.

The historical data trend for HOOKIPA Pharma's Insider Ownership can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

HOOKIPA Pharma Insider Ownership Chart

HOOKIPA Pharma Historical Data

The historical data trend for HOOKIPA Pharma can be seen below:

2025-07-31 2025-08-31 2025-09-30 2025-10-31 2025-11-30 2026-01-31 2026-02-28 2026-05-31 2026-06-30 2026-07-31
Insider Ownership 4.87 4.87 4.87 4.62 4.62 4.62 4.62 4.60 4.60 4.60
HOOK
50GF Score
HOOKIPA Pharma Inc HOOK
Insider Ownership is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

HOOKIPA Pharma Insider Ownership Calculation

The percentage of shares that are owned by company insiders relative to the total shares outstanding.

Frequently Asked Questions Learn more about Insider Ownership →
What does a Insider Ownership of 4.60 % mean?
HOOKIPA Pharma (HOOK) has a Insider Ownership of 4.60 % as of Aug. 15, 2026. Insider ownership equals the percent of shares owned by company insiders relative to total shares. View historical data on HOOKIPA Pharma and its competitors.
Is HOOKIPA Pharma's Insider Ownership too high?
HOOKIPA Pharma's current Insider Ownership is 4.60 %. Overall, HOOKIPA Pharma has a GF Score™ of 50/100, reflecting its overall financial health beyond just this single metric.
How does HOOKIPA Pharma's Insider Ownership compare to COCP and LNAI?
HOOKIPA Pharma's Insider Ownership of 4.60 % can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Insider Ownership for a Biotechnology company?
A good Insider Ownership depends on the Biotechnology industry context. However, Insider Ownership should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Insider Ownership mean?
A high Insider Ownership can signal that a stock is expensive relative to its fundamentals. Insider ownership equals the percent of shares owned by company insiders relative to total shares. View historical data on HOOKIPA Pharma and its competitors. HOOKIPA Pharma's current Insider Ownership is 4.60 %. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is HOOKIPA Pharma stock overvalued right now?
HOOKIPA Pharma (HOOK) has a current Insider Ownership of 4.60 %. The current Insider Ownership is 4.60 %. HOOKIPA Pharma's overall GF Score™ is 50/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Insider Ownership calculated?
Insider Ownership is calculated from a company's financial statements. For HOOKIPA Pharma (HOOK), the current Insider Ownership is 4.60 % as of Aug. 15, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

HOOKIPA Pharma Business Description

Address 350 Fifth Avenue, 72nd Floor, Suite 7240, New York, NY, USA, 10118
HOOKIPA Pharma Inc is a clinical-stage biopharmaceutical company developing a class of immunotherapeutics targeting infectious diseases and cancers based on its proprietary arenavirus platform that is designed to reprogram the body's immune system. The company's product candidates are designed to induce specific, robust and durable CD8+ T cells and antibodies to eliminate cancers and serious infectious diseases. Its pipeline includes biological therapies for oncology, targeting human papillomavirus type 16-positive (HPV16+) cancers, KRAS mutated cancers, and other targets. In addition, It is also focused to develop therapies that are intended to provide functional cures for hepatitis B virus (HBV) and human immunodeficiency virus-1 (HIV-1).
50GF Score

Get the complete analysis for HOOK

Insider Ownership is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$1.15
Price